Loading stock data…
$11.64-0.03 (-0.26%)
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States.
Medifast, Inc. in the Consumer Cyclical sector is trading at $11.64 with a market capitalization of $130M. Wall Street consensus targets $12.00 (1 analysts), implying a +3.1% move over the next 12 months. The stock is currently 14% below its 52-week high of $13.58, remaining 3.5% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $76.38M↑ | $76.04M↑ | $75.10M↓ | $89.41M↓ | $105.56M |
| Gross Profit | $53.40M↑ | $51.76M↓ | $52.14M↓ | $62.16M↓ | $76.64M |
| Operating Income | -$4.33M↓ | -$3.29M↑ | -$7.80M↓ | -$4.08M↓ | -$1.07M |
| Net Income | -$3.10M↓ | -$2.12M↑ | -$18.12M↓ | -$2.26M↓ | $2.48M |
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy li...